← Leaderboards
Jen Jen Yeh
Univ Of North Carolina Chapel Hill
$14,819,320
Attributed
$27,057,627
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,658,542 · 17
By mechanism
P50$11,247,812 · 5
R01$10,051,026 · 4
U01$5,972,746 · 2
T32$4,451,305 · 2
U24$3,223,979 · 2
P30$711,674 · 2
Top collaborators
- Gary L. Johnson12 shared
- Benjamin Raphael10 shared
- Susan Tsai8 shared
- William Y Kim7 shared
- Naim Ur Rashid7 shared
- Lee M Graves5 shared
- Wenbin Lin5 shared
- Alisa S Wolberg5 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Katherine A. Hoadley$3,478,334
- David N Hayes$17,915,459
- Fernando Pardo-Manuel De Villena$22,529,272
- Miroslav Styblo$11,778,382
- Rebecca Fry$32,078,226
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorClinical TrialsMalignant Neoplasm Of PancreasResponseMalignant NeoplasmsSamplingCellsSignal TransductionComputing MethodologiesInnovationGemcitabineProgramsKinase InhibitorClinicTumor MicroenvironmentCohortComplexPhosphotransferasesInternationalTechnologyBaseResearch PersonnelNeoplasm MetastasisGenes
Grant awards (75)
Selective Targeting of Pancreatic Cancer SPORE$2,158,912
P50 · FY2025 · CA · contact PI
Integrating tumor and stroma to understand and predict treatment response$914,890
U01 · FY2025 · CA · contact PI
Targeted EGFR for basal subtype pancreatic cancer$639,879
R01 · FY2025 · CA · contact PI
Project 3: Transcriptomic subtypes, response predictions, and therapy selection$473,937
P50 · FY2025 · CA · contact PI
UNC Integrated Translational Oncology Program (UNC-iTOP)$440,302
T32 · FY2025 · CA · contact PI
Pathway, Network and Spatiotemporal Integration of Cancer Genomics Data$307,434
U24 · FY2025 · CA
SToP Cancer SPORE: Administrative Core A$167,361
P50 · FY2025 · CA · contact PI
Selective Targeting of Pancreatic Cancer SPORE$2,079,098
P50 · FY2024 · CA · contact PI
Integrating tumor and stroma to understand and predict treatment response$869,831
U01 · FY2024 · CA · contact PI
Targeted EGFR for basal subtype pancreatic cancer$639,879
R01 · FY2024 · CA · contact PI
UNC Integrated Translational Oncology Program (UNC-iTOP)$567,329
T32 · FY2024 · CA · contact PI
Project 3: Transcriptomic subtypes, response predictions, and therapy selection$459,209
P50 · FY2024 · CA · contact PI
Pathway, Network and Spatiotemporal Integration of Cancer Genomics Data$291,430
U24 · FY2024 · CA
Cancer Research Career Enhancement and Related Activities$164,234
P30 · FY2024 · CA · contact PI
SToP Cancer SPORE: Administrative Core A$160,662
P50 · FY2024 · CA · contact PI
Selective Targeting of Pancreatic Cancer SPORE$86,682
P50 · FY2024 · CA · contact PI
Project 3: Transcriptomic subtypes, response predictions, and therapy selection$86,682
P50 · FY2024 · CA · contact PI
Integrating tumor and stroma to understand and predict treatment response$85,780
U01 · FY2024 · CA · contact PI
Selective Targeting of Pancreatic Cancer SPORE$2,057,187
P50 · FY2023 · CA · contact PI
Integrating tumor and stroma to understand and predict treatment response$924,643
U01 · FY2023 · CA · contact PI
UNC Integrated Translational Oncology Program (UNC-iTOP)$569,539
T32 · FY2023 · CA · contact PI
Project 3: Transcriptomic subtypes, response predictions, and therapy selection$411,480
P50 · FY2023 · CA · contact PI
Pathway, Network and Spatiotemporal Integration of Cancer Genomics Data$301,101
U24 · FY2023 · CA
Cancer Research Career Enhancement and Related Activities$182,480
P30 · FY2023 · CA · contact PI
SToP Cancer SPORE: Administrative Core A$158,428
P50 · FY2023 · CA · contact PI
Integrating tumor and stroma to understand and predict treatment response$90,295
U01 · FY2023 · CA · contact PI
Project 3: Transcriptomic subtypes, therapy selection and response$83,974
P50 · FY2023 · CA · contact PI
Selective Targeting of Pancreatic Cancer SPORE$83,974
P50 · FY2023 · CA · contact PI
Role of cingulin in FOLFIRINOX resistance$15,050
P50 · FY2023 · CA · contact PI
Project 3: Transcriptomic subtypes, response predictions, and therapy selection$15,050
P50 · FY2023 · CA · contact PI
Effect of JAK and RIPK2 inhibition on CAF and cancer cell crosstalk$15,050
U01 · FY2023 · CA · contact PI
Selective Targeting of Pancreatic Cancer SPORE$2,120,012
P50 · FY2022 · CA · contact PI
Integrating tumor and stroma to understand and predict treatment response$945,906
U01 · FY2022 · CA · contact PI
UNC Integrated Translational Oncology Program (UNC-iTOP)$541,135
T32 · FY2022 · CA · contact PI
Project 3: Transcriptomic subtypes, response predictions, and therapy selection$471,647
P50 · FY2022 · CA · contact PI
Pathway, Network and Spatiotemporal Integration of Cancer Genomics Data$307,697
U24 · FY2022 · CA
Enhancement Training for the Next Generation of Translational Ph.D. Scientists$192,641
T32 · FY2022 · GM
Cancer Research Career Enhancement and Related Activities$182,480
P30 · FY2022 · CA · contact PI
SToP Cancer SPORE: Administrative Core A$158,467
P50 · FY2022 · CA · contact PI
Tumor Subtypes and Therapy Response in Pancreatic Cancer$806,124
R01 · FY2021 · CA · contact PI
UNC Integrated Translational Oncology Program (UNC-iTOP)$572,494
T32 · FY2021 · CA · contact PI
Pathway, Network and Spatiotemporal Integration of Cancer Genomics Data$338,099
U24 · FY2021 · CA
Cancer Research Career Enhancement and Related Activities$182,480
P30 · FY2021 · CA · contact PI
Enhancement Training for the Next Generation of Translational Ph.D. Scientists$179,548
T32 · FY2021 · GM
Tumor subtypes and therapy response in pancreatic cancer$824,656
R01 · FY2020 · CA · contact PI
UNC Integrated Translational Oncology Program (UNC-iTOP)$579,408
T32 · FY2020 · CA · contact PI
Pathway and Network Integration of Cancer Genomics and Clinical Data$322,857
U24 · FY2020 · CA
Enhancement Training for the Next Generation of Translational Ph.D. Scientists$177,318
T32 · FY2020 · GM
Tumor subtypes and therapy response in pancreatic cancer$799,917
R01 · FY2019 · CA · contact PI
The adaptive kinome in pancreatic cancer$575,301
R01 · FY2019 · CA · contact PI
Pathway and Network Integration of Cancer Genomics and Clinical Data$315,930
U24 · FY2019 · CA
UNC Integrated Translational Oncology Program (UNC-iTOP)$283,433
T32 · FY2019 · CA · contact PI
Enhancement Training for the Next Generation of Translational Ph.D. Scientists$175,141
T32 · FY2019 · GM
Purity Independent SIngle Sample Tumor Classifier for Pancreatic Cancer$171,400
R01 · FY2019 · CA · contact PI
The adaptive kinome in pancreatic cancer$593,093
R01 · FY2018 · CA · contact PI
Tumor subtypes and therapy response in pancreatic cancer$591,406
R01 · FY2018 · CA · contact PI
Pathway and Network Integration of Cancer Genomics and Clinical Data$326,816
U24 · FY2018 · CA
Enhancement Training for the Next Generation of Translational Ph.D. Scientists$173,017
T32 · FY2018 · GM
Tumor subtypes and therapy response in pancreatic cancer$600,010
R01 · FY2017 · CA · contact PI
The adaptive kinome in pancreatic cancer$593,093
R01 · FY2017 · CA · contact PI
Pathway and Network Integration of Cancer Genomics and Clinical Data$336,518
U24 · FY2017 · CA
Tumor subtypes and therapy response in pancreatic cancer$600,010
R01 · FY2016 · CA · contact PI
The adaptive kinome in pancreatic cancer$570,696
R01 · FY2016 · CA · contact PI
Pathway and Network Integration of Cancer Genomics and Clinical Data$376,097
U24 · FY2016 · CA
The adaptive kinome in pancreatic cancer$573,723
R01 · FY2015 · CA · contact PI
Nanoscale Metal-organic Frameworks for Imaging and Therapy of Pancreatic Cancer$416,929
U01 · FY2014 · CA
Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment$288,951
R01 · FY2014 · CA · contact PI
Nanoscale Metal-organic Frameworks for Imaging and Therapy of Pancreatic Cancer$460,295
U01 · FY2013 · CA
Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment$280,014
R01 · FY2013 · CA · contact PI
Nanoscale Metal-organic Frameworks for Imaging and Therapy of Pancreatic Cancer$339,461
U01 · FY2012 · CA
Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment$297,887
R01 · FY2012 · CA · contact PI
Nanoscale Metal-organic Frameworks for Imaging and Therapy of Pancreatic Cancer$447,906
U01 · FY2011 · CA
Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment$297,887
R01 · FY2011 · CA · contact PI
Nanoscale Metal-organic Frameworks for Imaging and Therapy of Pancreatic Cancer$461,760
U01 · FY2010 · CA
Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment$307,100
R01 · FY2010 · CA · contact PI